^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Anal Carcinoma |
| Drug: | capecitabine (Thymidylate synthase inhibitor) + Mitotie (mitomycin) (Alkylating agent) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
02/16/2021
Excerpt:
...the panel recommends mitomycin/capecitabine plus radiation as an alternative to mitomycin/5-FU plus radiation in the setting of stage I through III anal cancer.
